» Articles » PMID: 6161181

Serologic and Immunochemical Characterization of the Specificity of Four Monoclonal Antibodies to Distinct Antigenic Determinants Expressed on Subpopulations of Human Ia-like Antigens

Overview
Journal J Immunol
Date 1981 Feb 1
PMID 6161181
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Serologic and immunochemical assays showed that the monoclonal antibodies Q2/70, Q2/80, Q5/6, and Q5/13 react with human Ia-like antigens. Each monoclonal antibody recognizes distinct antigenic determinants that are different from those defining the serologic polymorphism of Ia-like antigens defined by conventional alloantisera and are expressed on subpopulations of Ia-like antigens. The determinants recognized by the MoAb Q2/70 and Q5/13 are expressed on all HLA-DR allospecificities tested, whereas those reacting with the MoAb Q2/80 and Q5/6 are not detectable on HLA-DR5 and HLA-DR7 allospecificities, respectively.

Citing Articles

Serafino Zappacosta: An Enlightened Mentor and Educator.

Carbone E, De Felice M, Di Rosa F, DOro U, Fontana S, La Cava A Front Immunol. 2020; 11:217.

PMID: 32117323 PMC: 7031500. DOI: 10.3389/fimmu.2020.00217.


CG Dinucleotides of class II MHC genes are mutation hot-spots.

Gambari R, Piva R, Volinia S, Orlando P, Nastruzzi C, Giacomini P Cytotechnology. 2012; 1(2):133-8.

PMID: 22358564 DOI: 10.1007/BF00146813.


Majority of gliadin-specific T-cell clones from celiac small intestinal mucosa produce interferon-gamma and interleukin-4.

Troncone R, Gianfrani C, Mazzarella G, Greco L, Guardiola J, Auricchio S Dig Dis Sci. 1998; 43(1):156-61.

PMID: 9508518 DOI: 10.1023/a:1018896625699.


Generation and characterization of two human alpha/beta T cell clones. Recognizing autologous breast tumor cells through an HLA- and TCR/CD3-independent pathway.

Nistico P, De Berardinis P, Morrone S, Alonzi T, Buono C, Venturo I J Clin Invest. 1994; 94(4):1426-31.

PMID: 7929817 PMC: 295272. DOI: 10.1172/JCI117479.


Heterogeneity of human melanoma-associated antigens defined by monoclonal antibodies and conventional xenoantisera.

Wilson B, Kay N, Imai K, Ferrone S Cancer Immunol Immunother. 1982; 13(1):69-74.

PMID: 7159874 PMC: 11039084. DOI: 10.1007/BF00200204.